Quality of data from cancer registries in Italy: An appraisal

IF 2.4 3区医学 Q3 ONCOLOGY

Cancer Epidemiology Pub Date : 2025-05-03 DOI:10.1016/j.canep.2025.102829

Buzzoni Carlotta , Russo Antonio Giampiero , Zarcone Maurizio , Fusco Mario , Contiero Paolo , Tagliabue Giovanna , Fabiano Sabrina , Perotti Viviana , Stracci Fabrizio , Mazzucco Walter , Crocetti Emanuele , AIRTUM Working Group

{"title":"Quality of data from cancer registries in Italy: An appraisal","authors":"Buzzoni Carlotta , Russo Antonio Giampiero , Zarcone Maurizio , Fusco Mario , Contiero Paolo , Tagliabue Giovanna , Fabiano Sabrina , Perotti Viviana , Stracci Fabrizio , Mazzucco Walter , Crocetti Emanuele , AIRTUM Working Group","doi":"10.1016/j.canep.2025.102829","DOIUrl":null,"url":null,"abstract":"<div><div>We report the results of the quality assessment on data collected by cancer registries belonging to the Italian network of Cancer Registries (AIRTUM). For all malignant cancers diagnosed in 2013–2017, overall percentages of cases known from the death certificate only (DCO), and those of cases with cyto-histological confirmation (MV), were provided. The overall percentage of DCOs was small (1.2 %). The percentage of microscopic verification was overall high (87.6 %), with some variations among registries. DCO proportion varied from 0.1 % for cutaneous melanoma to 3.8 % for liver and pancreatic tumours. Differences across sites in MV proportion were linked to the different diagnostics. The rate of cases lost to follow-up was on average very low (0.7 %). This quality evaluation confirmed that data provided by the Italian cancer registries were affordable.</div></div>","PeriodicalId":56322,"journal":{"name":"Cancer Epidemiology","volume":"97 ","pages":"Article 102829"},"PeriodicalIF":2.4000,"publicationDate":"2025-05-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Cancer Epidemiology","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S187778212500089X","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"ONCOLOGY","Score":null,"Total":0}

引用次数: 0

Abstract

We report the results of the quality assessment on data collected by cancer registries belonging to the Italian network of Cancer Registries (AIRTUM). For all malignant cancers diagnosed in 2013–2017, overall percentages of cases known from the death certificate only (DCO), and those of cases with cyto-histological confirmation (MV), were provided. The overall percentage of DCOs was small (1.2 %). The percentage of microscopic verification was overall high (87.6 %), with some variations among registries. DCO proportion varied from 0.1 % for cutaneous melanoma to 3.8 % for liver and pancreatic tumours. Differences across sites in MV proportion were linked to the different diagnostics. The rate of cases lost to follow-up was on average very low (0.7 %). This quality evaluation confirmed that data provided by the Italian cancer registries were affordable.

查看原文本刊更多论文

意大利癌症登记数据的质量：评估

我们报告了意大利癌症登记处网络（AIRTUM）收集的癌症登记处数据的质量评估结果。对于2013-2017年诊断出的所有恶性癌症，提供了仅从死亡证明（DCO）得知的病例的总体百分比，以及细胞组织学证实（MV）的病例的总体百分比。DCOs的总体百分比很小（1.2 %）。显微验证的百分比总体上很高（87.6% %），在注册中心之间有一些变化。DCO比例从皮肤黑色素瘤的0.1 %到肝脏和胰腺肿瘤的3.8 %不等。不同位点间MV比例的差异与不同的诊断方法有关。失访率平均很低（0.7 %）。这一质量评价证实，意大利癌症登记处提供的数据是负担得起的。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Cancer Epidemiology 医学-肿瘤学

CiteScore

4.50

自引率

3.80%

发文量

200

审稿时长

39 days

期刊介绍： Cancer Epidemiology is dedicated to increasing understanding about cancer causes, prevention and control. The scope of the journal embraces all aspects of cancer epidemiology including: • Descriptive epidemiology • Studies of risk factors for disease initiation, development and prognosis • Screening and early detection • Prevention and control • Methodological issues The journal publishes original research articles (full length and short reports), systematic reviews and meta-analyses, editorials, commentaries and letters to the editor commenting on previously published research.